Investors with a lot of money to spend have taken a bullish stance on Alcoa (NYSE: AA).And retail traders should know.We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AA, it often means somebody knows something is about to happen.Today, Benzinga's options scanner spotted 8 options trades for Alcoa.This isn't normal.The over ...

Organigram Global Inc (NASDAQ: OGI) shares are trading sharply higher Monday afternoon, joining a rally across the cannabis sector. The surge follows a social media post from President Donald Trump over the weekend, in which he promoted the potential health benefits of cannabis and signaled a potential shift in federal drug policy. This news has renewed optimism for the cannabis industry.OGI shares are testing new highs. See the full story here.What Else: OrganiGram, a major Canadian cannabis producer, coul ...

Jim Cramer just tossed another log on the bank-stock fire. Fresh off the buzz around Electronic Arts Inc's (NASDAQ: EA) deal, the Mad Money host says JPMorgan Chase & Co (NYSE: JPM) and Goldman Sachs Group Inc (NYSE: GS) are "still cheap on a P/E basis" — a contrarian take when many investors think financials are tapped out.Track GS stock here.Valuations That Defy The TapeThe intrigue is simple: JPMorgan trades at just over 15.6 times forward earnings, Goldman closer to 15.3 times, per Benzinga Pro data. Co ...

Barrick Mining (NYSE: B) announced the resignation of President and CEO Mark Bristow today. After nearly seven years at the helm, the South African-born mining veteran departs without explanation, leaving investors to speculate on what prompted such an unexpected move.Effective immediately, Mark Hill, head of the company's Latin American and Asia-Pacific operations, has stepped in as interim CEO while the board begins a global search for a permanent replacement.“On behalf of the Board, I want to thank Mark ...

In the current session, the stock is trading at $195.03, after a 0.97% spike. Over the past month, Howmet Aerospace Inc. (NYSE: HWM) stock increased by 10.02%, and in the past year, by 88.83%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Howmet Aerospace P/E Compared to CompetitorsThe P/E ratio measures the current share price to the company's EPS. It is used by long-term investor ...

Financial giants have made a conspicuous bullish move on RH. Our analysis of options history for RH (NYSE: RH) revealed 20 unusual trades.Delving into the details, we found 45% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $484,441, and 9 were calls, valued at $719,770.Predicted Price RangeAnalyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $175.0 to $310. ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Rocket Companies.Looking at options history for Rocket Companies (NYSE: RKT) we detected 18 trades.If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades with bullish expectations and 27% with bearish.From the overall spotted trades, 5 are puts, for a total amount of $369,944 and 13, calls, for a total amount of $731,836.What's The Price Target?Based on the trading activity, it ...

临床试验结果 - 公司公布VELA-1和VELA-2三期试验第16周结果 主要终点采用HiSCR75标准（脓肿和炎性结节计数减少75%且无新增脓肿或引流隧道）[1] - 试验共纳入838名患者 设计采用120mg剂量sonelokimab与安慰剂对照 第16周读取HiSCR75数据[2] - 所有关键终点均达到统计学显著性 p值小于0.001 包括病灶计数和患者报告结局[3] - 第16周时VELA-1试验组HiSCR75应答率为34.8% VELA-2试验组为35.9%[5] - 安慰剂组应答率VELA-1为17.5%（符合历史三期试验13%-18%范围） VELA-2为25.6%（高于预期）[5] 药物疗效表现 - sonelokimab在第4周就显示出统计学显著的HiSCR75应答[3] - 初步分析显示16周后应答持续改善 安慰剂组交叉给药后在20周达到与初始试验组相似应答水平[4] - 两个试验均实现所有关键次要终点的统计学显著性 包括HiSCR50和IHS4-55等病灶计数指标[6] - 约30%患者在两项试验中实现疼痛显著减轻（最严重疼痛NRS评分改善至少3分）[6] - 近60%患者实现DLQI有临床意义的改善（4分或以上） 较对照组高出约20个百分点[7] 安全性及管理层评价 - 药物安全性良好 与既往研究一致 未出现新的安全信号[7] - 首席科学官表示对VELA-2较高安慰剂应答率感到失望 但对sonelokimab在所有终点的一致性表现感到鼓舞[7] 市场反应 - 公司股价单日暴跌超过90% 报收6.18美元[8]

Detroit Lions rookie wide receiver Isaac Teslaa may not be one of the most recognizable NFL newcomers in 2025, but his one-handed highlight-reel catches are certainly helping. A collaboration with Ford Motor Co (NYSE: F) might help soon, too.F is trading near recent highs. Get the scoop here.What Happened: As a member of the Detroit Lions, Teslaa calls Ford Field home and plays in a league that counts Ford as a sponsor. The automaker took things one step further to make sure that when it comes to electric v ...

Silver is in focus following a scorching rally, and ETFs tied to the metal are making the headlines. The iShares Silver Trust (NYSE: SLV), abrdn Physical Silver Shares ETF (NYSE: SIVR), Global X Silver Miners ETF (NYSE: SIL) and Amplify Junior Silver Miners ETF (NYSE: SILJ) are all being talked about as the metal crosses $46 per ounce, its highest since May 2011. The funds are up 1.9%, 2%, 2.5% and 3.2%, respectively.SLV shares are at critical resistance. Check the full analysis here.SLV and SIVR are still ...